A Randomized Trial Of PF-00299804 Taken Orally Versus Erlotinib Taken Orally For Treatment Of Advanced Non-Small Cell Lung Cancer That Has Progressed After One Or Two Prior Chemotherapy Regimen

This study is ongoing, but not recruiting participants.

Study NCT00769067 Information provided by Pfizer

First Received: October 7, 2008 Last Updated: February 5, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	September 2012
Primary Completion Date:	October 2010 (Final data collection date for primary outcome measure)
Certification - "Seeking Initial Approval":	Submission Date: November 15, 2011